BR9909809A - Sequências de oligonucleotìdeo anti-sentido de neuropilina e métodos de usar as mesmas para modular o desenvolvimento de célula - Google Patents

Sequências de oligonucleotìdeo anti-sentido de neuropilina e métodos de usar as mesmas para modular o desenvolvimento de célula

Info

Publication number
BR9909809A
BR9909809A BR9909809-1A BR9909809A BR9909809A BR 9909809 A BR9909809 A BR 9909809A BR 9909809 A BR9909809 A BR 9909809A BR 9909809 A BR9909809 A BR 9909809A
Authority
BR
Brazil
Prior art keywords
cell development
neuropilin
methods
antisense oligonucleotide
oligonucleotide sequences
Prior art date
Application number
BR9909809-1A
Other languages
English (en)
Inventor
Jim A Wright
Aiping H Young
Yoon S Lee
Original Assignee
Genesense Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genesense Technologies Inc filed Critical Genesense Technologies Inc
Publication of BR9909809A publication Critical patent/BR9909809A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Patente de Invenção: <B>"SEQuêNCIAS DE OLIGONUCLEOTìDEO ANTI SENTIDO DE NEUROPILINA E MéTODOS DE USAR AS MESMAS PARA MODULAR O DESENVOLVIMENTO DE CéLULA"<D>. Esta invenção refere-se a complementares de oligonucleotídeos para os genes de neuropilina que modulam o desenvolvimento da célula de tumor e a angiogênese em mamíferos. Esta invenção também está relacionada aos métodos de usar tais compostos na inibição do desenvolvimento das células de tumor e na angiogênese em mamíferos. Esta invenção também refere-se a composições farmacêuticas que compreendam um excipiente farmaceuticamente aceitável e uma quantidade eficaz de um composto desta invenção.
BR9909809-1A 1998-04-23 1999-04-23 Sequências de oligonucleotìdeo anti-sentido de neuropilina e métodos de usar as mesmas para modular o desenvolvimento de célula BR9909809A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8279198P 1998-04-23 1998-04-23
PCT/CA1999/000324 WO1999055855A2 (en) 1998-04-23 1999-04-23 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth

Publications (1)

Publication Number Publication Date
BR9909809A true BR9909809A (pt) 2000-12-19

Family

ID=22173486

Family Applications (2)

Application Number Title Priority Date Filing Date
BR9909809-1A BR9909809A (pt) 1998-04-23 1999-04-23 Sequências de oligonucleotìdeo anti-sentido de neuropilina e métodos de usar as mesmas para modular o desenvolvimento de célula
BR9909859-8A BR9909859A (pt) 1998-04-23 1999-04-23 Sequências de oligonucleotìdeos anti-sentido do fator de crescimento semelhante à insulina ii e métodos de uso das mesmas para modular o crescimento celular

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR9909859-8A BR9909859A (pt) 1998-04-23 1999-04-23 Sequências de oligonucleotìdeos anti-sentido do fator de crescimento semelhante à insulina ii e métodos de uso das mesmas para modular o crescimento celular

Country Status (11)

Country Link
US (2) US6417169B1 (pt)
EP (2) EP1073728A2 (pt)
JP (2) JP2002512792A (pt)
KR (2) KR20010042849A (pt)
CN (2) CN1298445A (pt)
AU (2) AU747639C (pt)
BR (2) BR9909809A (pt)
CA (2) CA2326824A1 (pt)
IL (2) IL138976A0 (pt)
NZ (2) NZ508353A (pt)
WO (2) WO1999055855A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040006220A1 (en) * 2002-07-02 2004-01-08 Isis Pharmaceuticals Inc. Antisense modulation of insulin-like growth factor 2 expression
US6316259B1 (en) * 2000-01-21 2001-11-13 Isis Pharmaceuticals, Inc. Antisense inhibition of glycogen synthase kinase 3 alpha expression
US6653467B1 (en) * 2000-04-26 2003-11-25 Jcr Pharmaceutical Co., Ltd. Medicament for treatment of Duchenne muscular dystrophy
AUPR030900A0 (en) * 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex
KR100441201B1 (ko) * 2001-09-10 2004-07-23 대한민국 리포터 유전자를 포함하는 티벡터용 플라스미드 및 그 제조방법
EP1439192A1 (en) * 2003-01-15 2004-07-21 Xerion Pharmaceuticals AG Neuropilin-1 inhibitors
EP2270159B1 (en) 2003-05-21 2015-01-07 Andes Biotechnologies S.A. Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
WO2005049648A2 (en) * 2003-07-09 2005-06-02 The University Of Iowa Research Foundation Chimeric or fusion constructs of insulin-like growth factor binding proteins as chemotherapeutic agents
EP1661582A1 (en) * 2003-08-21 2006-05-31 Kyowa Hakko Kogyo Co., Ltd. Cancer metastasis inhibitor
US20060193772A1 (en) * 2003-09-24 2006-08-31 Atsushi Ochiai Drugs for treating cancer
KR100818332B1 (ko) * 2006-03-21 2008-04-02 퓨리메드 주식회사 녹용으로부터 분리된 신규 인슐린 유사 성장 인자 2의 폴리펩타이드 및 이의 유전자
CA2687247A1 (en) * 2007-05-17 2008-11-27 Genentech, Inc. Inhibition of tumor metastasis by anti neuropilin 2 antibodies
KR20120003187A (ko) * 2010-07-02 2012-01-10 한국생명공학연구원 Ｎｅｕｒｏｐｉｌｉｎ １ 유전자를 이용한 천식 진단 및 천식 치료제 스크리닝 방법
EP2522341A1 (en) 2011-05-13 2012-11-14 Tragex Pharma Pharmaceutical compositions comprising Neuropilin inhibitors, and their use for the prevention and/or treatment of angiogenic disorders and cancers
EP2997373A1 (en) * 2013-05-17 2016-03-23 MedImmune, LLC Receptors for b7-h4
EP2823816A1 (en) 2013-07-09 2015-01-14 Tragex Pharma Inhibitors of Neuropilin and use thereof for the treatment of Neuropilin-related diseases

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5225347A (en) 1989-09-25 1993-07-06 Innovir Laboratories, Inc. Therapeutic ribozyme compositions and expression vectors
US5766855A (en) 1991-05-24 1998-06-16 Buchardt, Deceased; Ole Peptide nucleic acids having enhanced binding affinity and sequence specificity
US5719262A (en) 1993-11-22 1998-02-17 Buchardt, Deceased; Ole Peptide nucleic acids having amino acid side chains
US5665544A (en) * 1992-05-27 1997-09-09 Amersham International Plc RNA fingerprinting to determine RNA population differences
WO1994008625A1 (en) 1992-10-21 1994-04-28 Temple University - Of The Commonwealth System Of Higher Education Combination of antineoplastic agent and antisense oligonucleotides for treatment of cancer
US6346398B1 (en) * 1995-10-26 2002-02-12 Ribozyme Pharmaceuticals, Inc. Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
US6391311B1 (en) * 1998-03-17 2002-05-21 Genentech, Inc. Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
AU1810499A (en) * 1997-12-09 1999-06-28 Children's Medical Center Corporation Antagonists of neuropilin receptor functional and use thereof

Also Published As

Publication number Publication date
EP1073728A2 (en) 2001-02-07
AU3402299A (en) 1999-11-16
BR9909859A (pt) 2000-12-19
US20020187954A1 (en) 2002-12-12
IL138977A0 (en) 2001-11-25
IL138976A0 (en) 2001-11-25
AU747639C (en) 2005-01-13
CA2326825A1 (en) 1999-11-04
WO1999055854A3 (en) 2000-06-29
AU749802B2 (en) 2002-07-04
WO1999055855A3 (en) 2000-01-06
JP2002512792A (ja) 2002-05-08
KR20010042848A (ko) 2001-05-25
WO1999055854A2 (en) 1999-11-04
NZ508354A (en) 2005-01-28
KR20010042849A (ko) 2001-05-25
US6417169B1 (en) 2002-07-09
CA2326824A1 (en) 1999-11-04
AU747639B2 (en) 2002-05-16
NZ508353A (en) 2005-01-28
EP1073729A2 (en) 2001-02-07
AU3402199A (en) 1999-11-16
JP2002512793A (ja) 2002-05-08
CN1298445A (zh) 2001-06-06
WO1999055855A2 (en) 1999-11-04
CN1298444A (zh) 2001-06-06

Similar Documents

Publication Publication Date Title
BR9909809A (pt) Sequências de oligonucleotìdeo anti-sentido de neuropilina e métodos de usar as mesmas para modular o desenvolvimento de célula
BR9916488A (pt) Inibidores de protease
BRPI9710372B8 (pt) composto, e, composição farmacêutica.
NZ335013A (en) Compositions comprising cytosine derivatives for the treatment of cancer
BR9804437A (pt) Compostos para a osteoporose
BR9909925A (pt) Compostos, composições farmacêuticas, e, processos para a fabricação de um composto, e de tratamento de um mamìfero sofrendo de doenças resultantes da autoimunidade e inflamação patológica
BR0009869A (pt) Método para inibir a produção e/ou secreção de citoquina, e, composição farmacêutica
BR0008922A (pt) Compostos úteis como agentes antiinflamatórios
BR9811585A (pt) Agonistas de vasopressinas tricìclicas
KR930003912A (ko) 울혈성 심장 마비 치료법
BR9814643A (pt) Inibidor de metaloprotease de ácido sulfona hidroxâmico aromático
AP9801222A0 (en) Proatease inhibitors.
BR9913319A (pt) Composições e métodos para tratamento de doenças mitocondriais
BR9811099A (pt) Inibidores de urocinase
BR9907847A (pt) Agentes anti-inflamatórios seletivos para glucocorticóides
MX9701819A (es) Dihidrobenzofurano y compuestos relacionados, utiles como agentes antiiflamatorios.
AR022423A1 (es) Compuestos derivados de acidos 2,3,4,5-tetrahidro-1h-[1,4]benzodiazepina-3-hidroxamicos, composicion farmaceutica que los comprenden, y el uso de losmismos para la manufactura de un medicamento
FI971934A0 (fi) Asyloituja bentsyyliglykosideja sileälihassolulisääntymisen inhibiittoreina
UA49089C2 (uk) Похідні вуглеводів та фармацевтична композиція на їх основі
BR0016217A (pt) Composto, processo para prepará-lo, composição farmacêutica, e, uso do composto
BR9907990A (pt) Sequência de oligonucleotideos complementares aos genes tiorredoxina ou tiorredoxina reductase e métodos de utilização dos mesmos para modular o crescimento de células
Ying et al. The sequential analysis of liver cell necrosis: inhibition of diethylnitrosamine-and dimethylnitrosamine-induced acute liver cell death by posttreatment with diethyldithiocarbamate.
BR0015122A (pt) Composição farmacêutica, e, método de tratamento de inflamação
UY26088A1 (es) Inhibidores de proteasas
BRPI0414812A (pt) método de inibir a expressão de genes resistentes a múltiplos medicamentos e de inibir a produção de proteìnas resultantes da expressão de tais gene, melhorando assim a efetividade dos agentes quimioterápicos para tratar cánceres

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.